Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 191

1.

25-Hydroxyvitamin D Inhibits Hepatitis C Virus Production in Hepatocellular Carcinoma Cell Line by a Vitamin D Receptor-Independent Mechanism.

Ravid A, Rapaport N, Issachar A, Erman A, Bachmetov L, Tur-Kaspa R, Zemel R.

Int J Mol Sci. 2019 May 13;20(9). pii: E2367. doi: 10.3390/ijms20092367.

2.

Teaching the Interplay Between Social Determinants of Health (SDH) and Health Outcomes: the ETGAR Student-Delivered Service.

Spitzer-Shohat S, Sagi D, Schuster M, Ben-Ami M, Rivo M, Tur-Kaspa R, Rudolf MCJ.

J Gen Intern Med. 2019 Jul;34(7):1103-1104. doi: 10.1007/s11606-019-04904-z. No abstract available.

PMID:
30859512
3.

Correction: Modeling suggests that microliter volumes of contaminated blood caused an outbreak of hepatitis C during computerized tomography.

Shteyer E, Shekhtman L, Zinger T, Harari S, Gafanovich I, Wolf D, Ivgi H, Barsuk R, Dery I, Armoni D, Rivkin M, Pipalia R, Eliav MC, Skorochod Y, Breuer GS, Tur-Kaspa R, Wiener YW, Stern A, Cotler SJ, Dahari H, Lurie Y.

PLoS One. 2019 Feb 7;14(2):e0212252. doi: 10.1371/journal.pone.0212252. eCollection 2019.

4.

Modeling suggests that microliter volumes of contaminated blood caused an outbreak of hepatitis C during computerized tomography.

Shteyer E, Shekhtman L, Zinger T, Harari S, Gafanovich I, Wolf D, Ivgi H, Barsuk R, Dery I, Armoni D, Rivkin M, Pipalia R, Cohen Eliav M, Skorochod Y, Breuer GS, Tur-Kaspa R, Weil Wiener Y, Stern A, Cotler SJ, Dahari H, Lurie Y.

PLoS One. 2019 Jan 15;14(1):e0210173. doi: 10.1371/journal.pone.0210173. eCollection 2019. Erratum in: PLoS One. 2019 Feb 7;14(2):e0212252.

5.

Transplantation of Livers from Old Donors: Pushing the Envelope Beyond the Seventh Decade.

Nesher E, Braun M, Eizner S, Issachar A, Cohen M, Shlomai A, Gurevich M, Tur-Kaspa R, Mor E.

Isr Med Assoc J. 2018 Dec;20(12):765-769.

6.

The utility of magnetic resonance cholangiopancreatography for the assessment of patients with elevated liver enzyme levels.

Benjaminov O, Bachar GN, Goldberg N, Benjaminov-Sclarovsky F, Tur-Kaspa R.

Eur J Gastroenterol Hepatol. 2013 Oct;25(10):1190-4. doi: 10.1097/MEG.0b013e328360762e.

PMID:
24002015
7.

The use of epitope arrays in immunodiagnosis of infectious disease: hepatitis C virus, a case study.

Siman-Tov DD, Zemel R, Tur Kaspa R, Gershoni JM.

Anal Biochem. 2013 Jan 15;432(2):63-70. doi: 10.1016/j.ab.2012.09.025. Epub 2012 Sep 24.

PMID:
23017878
8.

Extended peginterferon plus ribavirin treatment for 72 weeks versus standard peginterferon plus ribavirin treatment for 48 weeks in chronic hepatitis C genotype 1 infected slow-responder adult patients.

Katz LH, Goldvaser H, Gafter-Gvili A, Tur-Kaspa R.

Cochrane Database Syst Rev. 2012 Sep 12;(9):CD008516. doi: 10.1002/14651858.CD008516.pub2. Review.

PMID:
22972122
9.

Removal of hepatitis C virus-infected cells by a zymogenized bacterial toxin.

Shapira A, Shapira S, Gal-Tanamy M, Zemel R, Tur-Kaspa R, Benhar I.

PLoS One. 2012;7(2):e32320. doi: 10.1371/journal.pone.0032320. Epub 2012 Feb 16.

10.

Suppression of hepatitis C virus by the flavonoid quercetin is mediated by inhibition of NS3 protease activity.

Bachmetov L, Gal-Tanamy M, Shapira A, Vorobeychik M, Giterman-Galam T, Sathiyamoorthy P, Golan-Goldhirsh A, Benhar I, Tur-Kaspa R, Zemel R.

J Viral Hepat. 2012 Feb;19(2):e81-8. doi: 10.1111/j.1365-2893.2011.01507.x. Epub 2011 Aug 16.

PMID:
22239530
11.

Vitamin D: an innate antiviral agent suppressing hepatitis C virus in human hepatocytes.

Gal-Tanamy M, Bachmetov L, Ravid A, Koren R, Erman A, Tur-Kaspa R, Zemel R.

Hepatology. 2011 Nov;54(5):1570-9. doi: 10.1002/hep.24575.

PMID:
21793032
12.

The role of oncogenic viruses in the pathogenesis of hepatocellular carcinoma.

Zemel R, Issachar A, Tur-Kaspa R.

Clin Liver Dis. 2011 May;15(2):261-79, vii-x. doi: 10.1016/j.cld.2011.03.001. Review.

PMID:
21689612
13.

Engineered toxins "zymoxins" are activated by the HCV NS3 protease by removal of an inhibitory protein domain.

Shapira A, Gal-Tanamy M, Nahary L, Litvak-Greenfeld D, Zemel R, Tur-Kaspa R, Benhar I.

PLoS One. 2011 Jan 14;6(1):e15916. doi: 10.1371/journal.pone.0015916.

14.

Magnetic resonance cholangiopancreatography for the accurate diagnosis of biliary complications after liver transplantation: comparison with endoscopic retrograde cholangiography and percutaneous transhepatic cholangiography - long-term follow-up.

Katz LH, Benjaminov O, Belinki A, Geler A, Braun M, Knizhnik M, Aizner S, Shaharabani E, Sulkes J, Shabtai E, Pappo O, Atar E, Tur-Kaspa R, Mor E, Ben-Ari Z.

Clin Transplant. 2010 Sep-Oct;24(5):E163-9. doi: 10.1111/j.1399-0012.2010.01300.x.

PMID:
21039885
15.

Inhibition of protease-inhibitor-resistant hepatitis C virus replicons and infectious virus by intracellular intrabodies.

Gal-Tanamy M, Zemel R, Bachmatov L, Jangra RK, Shapira A, Villanueva RA, Yi M, Lemon SM, Benhar I, Tur-Kaspa R.

Antiviral Res. 2010 Oct;88(1):95-106. doi: 10.1016/j.antiviral.2010.08.001. Epub 2010 Aug 10.

16.

Lamivudine or adefovir dipivoxil alone or combined with immunoglobulin for preventing hepatitis B recurrence after liver transplantation.

Katz LH, Tur-Kaspa R, Guy DG, Paul M.

Cochrane Database Syst Rev. 2010 Jul 7;(7):CD006005. doi: 10.1002/14651858.CD006005.pub2. Review.

PMID:
20614442
17.

Prevention of recurrent hepatitis B virus infection after liver transplantation: hepatitis B immunoglobulin, antiviral drugs, or both? Systematic review and meta-analysis.

Katz LH, Paul M, Guy DG, Tur-Kaspa R.

Transpl Infect Dis. 2010 Aug 1;12(4):292-308. doi: 10.1111/j.1399-3062.2009.00470.x. Epub 2009 Nov 24. Review.

PMID:
20002355
18.

A comparison of transjugular and plugged-percutaneous liver biopsy in patients with contraindications to ordinary percutaneous liver biopsy and an "in-house" protocol for selecting the procedure of choice.

Atar E, Ben Ari Z, Bachar GN, Amlinski Y, Neyman C, Knizhnik M, Litvin S, Schmilovitz-Weiss H, Shapiro R, Bruckhaimer E, Tur-Kaspa R, Belenky A.

Cardiovasc Intervent Radiol. 2010 Jun;33(3):560-4. doi: 10.1007/s00270-009-9743-z. Epub 2009 Nov 12.

PMID:
19908088
19.

Bezafibrate treatment of primary biliary cirrhosis following incomplete response to ursodeoxycholic acid.

Hazzan R, Tur-Kaspa R.

J Clin Gastroenterol. 2010 May-Jun;44(5):371-3. doi: 10.1097/MCG.0b013e3181c115b3.

PMID:
19881358
20.

Expression of liver-specific markers in naïve adipose-derived mesenchymal stem cells.

Zemel R, Bachmetov L, Ad-El D, Abraham A, Tur-Kaspa R.

Liver Int. 2009 Oct;29(9):1326-37. doi: 10.1111/j.1478-3231.2009.02054.x. Epub 2009 Jun 5.

PMID:
19515222
21.

Postshunt hepatic encephalopathy in liver transplant recipients.

Braun MM, Bar-Nathan N, Shaharabani E, Aizner S, Tur-Kaspa R, Belenky A, Mor E, Ben-Ari ZZ.

Transplantation. 2009 Mar 15;87(5):734-9. doi: 10.1097/TP.0b013e318196340d.

PMID:
19295319
22.

Hepatitis C virus targets over-expression of arginase I in hepatocarcinogenesis.

Cao W, Sun B, Feitelson MA, Wu T, Tur-Kaspa R, Fan Q.

Int J Cancer. 2009 Jun 15;124(12):2886-92. doi: 10.1002/ijc.24265.

23.

Low weight predicts neutropenia and peginterferon alfa-2a dose reductions during treatment for chronic hepatitis C.

Rotman Y, Katz L, Cohen M, Cohen-Ezra O, Manhaim V, Braun M, Ben-Ari Z, Tur-Kaspa R.

J Viral Hepat. 2009 May;16(5):340-5. doi: 10.1111/j.1365-2893.2009.01079.x. Epub 2009 Feb 11.

PMID:
19220735
24.

Serum protein N-glycans profiling for the discovery of potential biomarkers for nonalcoholic steatohepatitis.

Chen C, Schmilovitz-Weiss H, Liu XE, Pappo O, Halpern M, Sulkes J, Braun M, Cohen M, Barak N, Tur-Kaspa R, Vanhooren V, Van Vlierberghe H, Libert C, Contreras R, Ben-Ari Z.

J Proteome Res. 2009 Feb;8(2):463-70. doi: 10.1021/pr800656e.

PMID:
19140676
25.

Endovascular diagnosis and intervention in patients with isolated hyperammonemia, with or without ascites, after liver transplantation.

Belenky A, Igov I, Konstantino Y, Bachar GN, Mor E, Graif F, Ben-Ari Z, Tur-Kaspa R, Atar E.

J Vasc Interv Radiol. 2009 Feb;20(2):259-63. doi: 10.1016/j.jvir.2008.11.003. Epub 2008 Dec 20.

PMID:
19097808
26.

Immunohistochemical evaluation of hepatic oval cell activation and differentiation toward pancreatic beta-cell phenotype in streptozotocin-induced diabetic mice.

Vorobeychik M, Bloch K, Zemel R, Bachmetov L, Tur-Kaspa R, Vardi P.

J Mol Histol. 2008 Aug;39(4):463-8. doi: 10.1007/s10735-008-9185-y. Epub 2008 Jul 31.

PMID:
18668329
27.

Sustained virologic response to treatment in 100% of patients recently infected, nosocomially, with HCV genotype 2.

Sikuler E, Tur-Kaspa R, Shemer-Avni Y, Delgado J, Zilberman D, Fich A, Baruch Y, Hyam E.

J Clin Gastroenterol. 2008 Jul;42(6):730-3. doi: 10.1097/MCG.0b013e31804c7053.

PMID:
18574394
28.

The 13C-caffeine breath test detects significant fibrosis in patients with nonalcoholic steatohepatitis.

Schmilovitz-Weiss H, Niv Y, Pappo O, Halpern M, Sulkes J, Braun M, Barak N, Rotman Y, Cohen M, Waked A, Tur-Kaspa R, Ben-Ari Z.

J Clin Gastroenterol. 2008 Apr;42(4):408-12. doi: 10.1097/MCG.0b013e318046ea65.

PMID:
18277896
29.

Inhibition of hepatitis C virus RNA replicons by peptide aptamers.

Trahtenherts A, Gal-Tanamy M, Zemel R, Bachmatov L, Loewenstein S, Tur-Kaspa R, Benhar I.

Antiviral Res. 2008 Mar;77(3):195-205. doi: 10.1016/j.antiviral.2007.12.013. Epub 2008 Jan 22.

PMID:
18243349
30.

Lamivudine prevents reactivation of hepatitis B and reduces mortality in immunosuppressed patients: systematic review and meta-analysis.

Katz LH, Fraser A, Gafter-Gvili A, Leibovici L, Tur-Kaspa R.

J Viral Hepat. 2008 Feb;15(2):89-102. doi: 10.1111/j.1365-2893.2007.00902.x. Review.

PMID:
18184191
31.

Iatrogenic transmission of hepatitis C virus (HCV) by an anesthesiologist: comparative molecular analysis of the HCV-E1 and HCV-E2 hypervariable regions.

Shemer-Avni Y, Cohen M, Keren-Naus A, Sikuler E, Hanuka N, Yaari A, Hayam E, Bachmatov L, Zemel R, Tur-Kaspa R.

Clin Infect Dis. 2007 Aug 15;45(4):e32-8. Epub 2007 Jul 10.

PMID:
17638183
32.

Serum globulin levels in predicting the extent of hepatic fibrosis in patients with recurrent post-transplant hepatitis C infection.

Schmilovitz-Weiss H, Cohen M, Pappo O, Sulkes J, Braun M, Tur-Kaspa R, Ben-Ari Z.

Clin Transplant. 2007 May-Jun;21(3):391-7.

PMID:
17488390
33.

Development of specific antibodies to an ARF protein in treated patients with chronic HCV infection.

Cohen M, Bachmatov L, Ben-Ari Z, Rotman Y, Tur-Kaspa R, Zemel R.

Dig Dis Sci. 2007 Sep;52(9):2427-32. Epub 2007 Apr 10.

PMID:
17436105
34.

Predictive value of serum globulin levels for the extent of hepatic fibrosis in patients with chronic hepatitis B infection.

Schmilovitz-Weiss H, Tovar A, Halpern M, Sulkes J, Braun M, Rotman Y, Tur-Kaspa R, Ben-Ari Z.

J Viral Hepat. 2006 Oct;13(10):671-7.

PMID:
16970598
35.

Monoclonal antibody HCV-AbXTL68 in patients undergoing liver transplantation for HCV: results of a phase 2 randomized study.

Schiano TD, Charlton M, Younossi Z, Galun E, Pruett T, Tur-Kaspa R, Eren R, Dagan S, Graham N, Williams PV, Andrews J.

Liver Transpl. 2006 Sep;12(9):1381-9.

36.

Recurrent hepatitis C virus disease after liver transplantation and concurrent biliary tract complications: poor outcome.

Katz LH, Mor E, Brown M, Bar-Nathan N, Shaharabani E, Sulkes J, Pappo O, Tur-Kaspa R, Ben-Ari Z.

Clin Transplant. 2006 Jul-Aug;20(4):465-70.

PMID:
16842523
37.

Clinical problem-solving. Search for the complication.

Salamon F, Hirsch R, Tur-Kaspa R, Kramer MR.

N Engl J Med. 2006 Mar 2;354(9):957-63. No abstract available.

PMID:
16510750
38.

Platelet-derived growth factor gene polymorphism in recurrent hepatitis C infection after liver transplantation.

Ben-Ari Z, Tambur AR, Pappo O, Sulkes J, Pravica V, Hutchinson I, Klein T, Tur-Kaspa R, Mor E.

Transplantation. 2006 Feb 15;81(3):392-7.

PMID:
16477226
39.

[Medical students' reactions to their experience in oncology and its contribution to their training].

Notzer N, Tur-Kaspa R.

Harefuah. 2006 Jan;145(1):32-5, 78. Hebrew.

PMID:
16450722
40.

Chronic hepatitis C virus infection in older adults.

Marcus EL, Tur-Kaspa R.

Clin Infect Dis. 2005 Dec 1;41(11):1606-12. Epub 2005 Oct 27. Review.

PMID:
16267733
41.

Inflammatory pseudotumor of the liver: a therapeutic dilemma.

Cohen M, Huminer D, Salamon F, Cohen M, Tur-Kaspa R.

Isr Med Assoc J. 2005 Jul;7(7):472-3. No abstract available.

42.

HCV NS3 serine protease-neutralizing single-chain antibodies isolated by a novel genetic screen.

Gal-Tanamy M, Zemel R, Berdichevsky Y, Bachmatov L, Tur-Kaspa R, Benhar I.

J Mol Biol. 2005 Apr 15;347(5):991-1003.

PMID:
15784258
43.

Lamivudine treatment for acute severe hepatitis B: a pilot study.

Schmilovitz-Weiss H, Ben-Ari Z, Sikuler E, Zuckerman E, Sbeit W, Ackerman Z, Safadi R, Lurie Y, Rosner G, Tur-Kaspa R, Reshef R.

Liver Int. 2004 Dec;24(6):547-51. Erratum in: Liver Int. 2005 Feb;25(1):196.

PMID:
15566503
44.

Genotype prevalence, viral load and outcome of hepatitis B virus precore mutant infection in stable patients and in patients after liver transplantation.

Ben-Ari Z, Ashur Y, Daudi N, Shmilovitz-Wiess H, Brown M, Sulkes J, Klein A, Mor E, Tur-Kaspa R, Shouval D.

Clin Transplant. 2004 Aug;18(4):415-22.

PMID:
15233819
45.

Role of cytokine gene polymorphism and hepatic transforming growth factor beta1 expression in recurrent hepatitis C after liver transplantation.

Ben-Ari Z, Pappo O, Druzd T, Sulkes J, Klein T, Samra Z, Gadba R, Tambur AR, Tur-Kaspa R, Mor E.

Cytokine. 2004 Jul 7;27(1):7-14.

PMID:
15207246
46.

Inhibition of hepatitis C virus NS3-mediated cell transformation by recombinant intracellular antibodies.

Zemel R, Berdichevsky Y, Bachmatov L, Benhar I, Tur-Kaspa R.

J Hepatol. 2004 Jun;40(6):1000-7.

PMID:
15158342
47.

Serum cholestasis markers as predictors of early outcome after liver transplantation.

Ben-Ari Z, Weiss-Schmilovitz H, Sulkes J, Brown M, Bar-Nathan N, Shaharabani E, Yussim A, Shapira Z, Tur-Kaspa R, Mor E.

Clin Transplant. 2004 Apr;18(2):130-6.

PMID:
15016125
48.

Role of circulating soluble CD40 as an apoptotic marker in liver disease.

Schmilovitz-Weiss H, Belinki A, Pappo O, Sulkes J, Melzer E, Kaganovski E, Kfir B, Tur-Kaspa R, Klein T, Ben-Ari Z.

Apoptosis. 2004 Mar;9(2):205-10.

PMID:
15004517
49.

Acute liver failure complicating ductal breast carcinoma: two cases and literature review.

Lowenthal A, Tur-Kaspa R, Brower RG, Almog Y.

Scand J Gastroenterol. 2003 Oct;38(10):1095-6. Review. No abstract available.

PMID:
14621287
50.

Radiofrequency ablation for the management of liver tumors.

Bachar GN, Greif F, Mor E, Tur-Kaspa R, Belenky A.

Isr Med Assoc J. 2003 Jul;5(7):496-500.

Supplemental Content

Loading ...
Support Center